Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel J Scherer

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Cardiovascular Diagnosis and Therapy|August 9, 2016
Future imaging of atherosclerosis: molecular imaging of coronary atherosclerosis with (18)F positron emission tomographyDaniel J Scherer, Peter J Psaltis
Vascular Health and Risk Management|April 8, 2015
Lowering triglycerides to modify cardiovascular risk: will icosapent deliver?Daniel J Scherer, Stephen J Nicholls
Archives of Medical Science : AMS|December 2, 2016
Inducing apolipoprotein A-I synthesis to reduce cardiovascular risk: from ASSERT to SUSTAIN and beyondBelinda A Di Bartolo, Daniel J Scherer, Stephen J Nicholls
Expert Opinion on Pharmacotherapy|December 6, 2014
Ongoing challenges for pharmacotherapy for dyslipidemiaAnthony D Pisaniello, Daniel J Scherer, Yu Kataoka, et al.
BMJ Case Reports|May 12, 2016
Non-traumatic spinal intradural haematoma: a rare case of paralysis following abciximab for ST elevation acute coronary syndromeGeoffrey R Wong, Daniel J Scherer, Adam J Nelson, et al.
Internal Medicine Journal|April 13, 2017
Targeting low-density lipoprotein cholesterol with PCSK9 inhibitorsDaniel J Scherer, Adam J Nelson, Peter J Psaltis, et al.
Journal of Cardiology Cases|December 15, 2018
Kounis syndrome and hypersensitivity myocarditis - One and the same? Insights from cardiac magnetic resonance imagingTimothy J Baillie, Daniel J Scherer, Dennis T L Wong, et al.
Heart, Lung & Circulation|February 14, 2022
Methamphetamine-Associated Cardiomyopathy: Addressing the Clinical ChallengesFiona Thoi, Daniel J Scherer, David M Kaye, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|April 21, 2017
PCSK9 Inhibitors in Hyperlipidemia: Current Status and Clinical OutlookBelinda Di Bartolo, Daniel J Scherer, Alex Brown, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|December 1, 2022
Cardiovascular magnetic resonance imaging characteristics in patients with methamphetamine-associated cardiomyopathyMichael B Stokes, Fiona Thoi, Daniel J Scherer, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Cardiovascular Diagnosis and Therapy|August 9, 2016
Future imaging of atherosclerosis: molecular imaging of coronary atherosclerosis with (18)F positron emission tomographyDaniel J Scherer, Peter J Psaltis
Vascular Health and Risk Management|April 8, 2015
Lowering triglycerides to modify cardiovascular risk: will icosapent deliver?Daniel J Scherer, Stephen J Nicholls
Archives of Medical Science : AMS|December 2, 2016
Inducing apolipoprotein A-I synthesis to reduce cardiovascular risk: from ASSERT to SUSTAIN and beyondBelinda A Di Bartolo, Daniel J Scherer, Stephen J Nicholls
Expert Opinion on Pharmacotherapy|December 6, 2014
Ongoing challenges for pharmacotherapy for dyslipidemiaAnthony D Pisaniello, Daniel J Scherer, Yu Kataoka, et al.
BMJ Case Reports|May 12, 2016
Non-traumatic spinal intradural haematoma: a rare case of paralysis following abciximab for ST elevation acute coronary syndromeGeoffrey R Wong, Daniel J Scherer, Adam J Nelson, et al.
Internal Medicine Journal|April 13, 2017
Targeting low-density lipoprotein cholesterol with PCSK9 inhibitorsDaniel J Scherer, Adam J Nelson, Peter J Psaltis, et al.
Journal of Cardiology Cases|December 15, 2018
Kounis syndrome and hypersensitivity myocarditis - One and the same? Insights from cardiac magnetic resonance imagingTimothy J Baillie, Daniel J Scherer, Dennis T L Wong, et al.
Heart, Lung & Circulation|February 14, 2022
Methamphetamine-Associated Cardiomyopathy: Addressing the Clinical ChallengesFiona Thoi, Daniel J Scherer, David M Kaye, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|April 21, 2017
PCSK9 Inhibitors in Hyperlipidemia: Current Status and Clinical OutlookBelinda Di Bartolo, Daniel J Scherer, Alex Brown, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|December 1, 2022
Cardiovascular magnetic resonance imaging characteristics in patients with methamphetamine-associated cardiomyopathyMichael B Stokes, Fiona Thoi, Daniel J Scherer, et al.
Pageof 2